Cargando…

Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment

Multiple myeloma develops primarily inside the bone marrow microenvironment, that confers pro-survival signals and drug resistance. 3D cultures that reproduce multiple myeloma-bone marrow interactions are needed to fully investigate multiple myeloma pathogenesis and response to drugs. To this purpos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belloni, Daniela, Heltai, Silvia, Ponzoni, Maurilio, Villa, Antonello, Vergani, Barbara, Pecciarini, Lorenza, Marcatti, Magda, Girlanda, Stefania, Tonon, Giovanni, Ciceri, Fabio, Caligaris-Cappio, Federico, Ferrarini, Marina, Ferrero, Elisabetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865414/ https://www.ncbi.nlm.nih.gov/pubmed/29326121 http://dx.doi.org/10.3324/haematol.2017.167486

Ejemplares similares

Ex-Vivo Dynamic 3-D Culture of Human Tissues in the RCCS™ Bioreactor Allows the Study of Multiple Myeloma Biology and Response to Therapy
por: Ferrarini, Marina, et al.
Publicado: (2013)

Correction: Ex-Vivo Dynamic 3-D Culture of Human Tissues in the RCCS™ Bioreactor Allows the Study of Multiple Myeloma Biology and Response to Therapy
por: Ferrarini, Marina, et al.
Publicado: (2013)

ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies
por: Botrugno, Oronza A., et al.
Publicado: (2019)

Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival
por: Di Lullo, Giulia, et al.
Publicado: (2015)

Correction: Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line
por: Agathangelidis, Andreas, et al.
Publicado: (2015)

Establishment and Characterization of PCL12, a Novel CD5(+) Chronic Lymphocytic Leukaemia Cell Line
por: Agathangelidis, Andreas, et al.
Publicado: (2015)

Protocol for generation of 3D bone marrow surrogate microenvironments in a rotary cell culture system
por: Belloni, Daniela, et al.
Publicado: (2022)

Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma
por: Di Lullo, Giulia, et al.
Publicado: (2019)

Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma
por: Calcinotto, Arianna, et al.
Publicado: (2015)

RESCUE OF HIPPO CO-ACTIVATOR YAP1 TRIGGERS DNA DAMAGE-INDUCED APOPTOSIS IN HEMATOLOGICAL CANCERS
por: Cottini, Francesca, et al.
Publicado: (2014)

Toll-like Receptors in Chronic Lymphocytic Leukemia
por: Muzio, Marta, et al.
Publicado: (2012)

Three-dimensional co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents
por: Barbaglio, Federica, et al.
Publicado: (2020)

Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models
por: Bianco, Mimma, et al.
Publicado: (2016)

3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target
por: Villa, Antonello, et al.
Publicado: (2019)

Minimal residual disease detection by next-generation sequencing in multiple myeloma: Promise and challenges for response-adapted therapy
por: Ferla, Valeria, et al.
Publicado: (2022)

A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells
por: Milan, Enrico, et al.
Publicado: (2015)

Autologous Pancreatic Islet Transplantation in Human Bone Marrow
por: Maffi, Paola, et al.
Publicado: (2013)

Bone Marrow Microenvironment in Multiple Myeloma Progression
por: Manier, S., et al.
Publicado: (2012)

Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma
por: Trudu, Matteo, et al.
Publicado: (2022)

Hypoxia inducible factor-1α regulates a pro-invasive phenotype in acute monocytic leukemia
por: Migliavacca, Jessica, et al.
Publicado: (2016)

Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease.
por: Pizzolo, G., et al.
Publicado: (1984)

Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment
por: Ho, Matthew, et al.
Publicado: (2022)

Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma
por: Ferreri, Andrés J.M., et al.
Publicado: (2022)

Marginal zone lymphoma: Diagnostic challenges among different entities
por: Bongiovanni, Lucia, et al.
Publicado: (2018)

Impact of cell fusion in myeloma marrow microenvironment on tumor progression
por: Wang, Ziyan, et al.
Publicado: (2018)

Selective Preservation of Bone Marrow Mature Recirculating but Not Marginal Zone B Cells in Murine Models of Chronic Inflammation
por: Traggiai, Elisabetta, et al.
Publicado: (2010)

Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment
por: Abdi, Jahangir, et al.
Publicado: (2014)

Exosomes in the Pathogenesis and Treatment of Multiple Myeloma in the Context of the Bone Marrow Microenvironment
por: Chen, Tianzeng, et al.
Publicado: (2020)

Targeted Approaches to Inhibit Sialylation of Multiple Myeloma in the Bone Marrow Microenvironment
por: Natoni, Alessandro, et al.
Publicado: (2019)

Editorial: The role of the bone marrow microenvironment in multiple myeloma evolution and therapy
por: Schinke, Carolina, et al.
Publicado: (2023)

P965: STEM-CELL MOBILIZATION WITH CYCLOPHOSPHAMIDE 4 G/M2 ALLOWS COLLECTION OF HIGH NUMBERS OF CD34+ CELLS AFTER DARA-VTD INDUCTION FOR MULTIPLE MYELOMA
por: Perini, Tommaso, et al.
Publicado: (2023)

Higher cyclophosphamide dose grants optimal stem cell collection after daratumumab-based induction in multiple myeloma
por: Liberatore, Carmine, et al.
Publicado: (2023)

Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics
por: Tavel, Laurette, et al.
Publicado: (2016)

JunB is a key regulator of multiple myeloma bone marrow angiogenesis
por: Fan, Fengjuan, et al.
Publicado: (2021)

MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment
por: Raimondi, Lavinia, et al.
Publicado: (2016)

Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma
por: Wang, Jinheng, et al.
Publicado: (2016)

Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma
por: Harmer, Danielle, et al.
Publicado: (2019)

The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma
por: Giannakoulas, Nikolaos, et al.
Publicado: (2021)

Multiple Myeloma-Derived Extracellular Vesicles Modulate the Bone Marrow Immune Microenvironment
por: Lopes, Raquel, et al.
Publicado: (2022)

Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study Group
por: Bila, Jelena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1u8p4208uqvhmh9s0a5dq32la5